These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 27594566)

  • 1. The CRISPR-Cas system - from bacterial immunity to genome engineering.
    Czarnek M; Bereta J
    Postepy Hig Med Dosw (Online); 2016 Sep; 70(0):901-16. PubMed ID: 27594566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances in CRISPR/Cas9-mediated gene editing].
    Li C; Cao W
    Sheng Wu Gong Cheng Xue Bao; 2015 Nov; 31(11):1531-42. PubMed ID: 26939437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems.
    Chylinski K; Le Rhun A; Charpentier E
    RNA Biol; 2013 May; 10(5):726-37. PubMed ID: 23563642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CRISPR/Cas9-based genome editing systems and the analysis of targeted genome mutations in plants].
    Ma XL; Liu YG
    Yi Chuan; 2016 Feb; 38(2):118-25. PubMed ID: 26907775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the Origin of CRISPR-Cas Technology: From Prokaryotes to Mammals.
    Mojica FJM; Montoliu L
    Trends Microbiol; 2016 Oct; 24(10):811-820. PubMed ID: 27401123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing CRISPR-Cas systems for bacterial genome editing.
    Selle K; Barrangou R
    Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas System: History and Prospects as a Genome Editing Tool in Microorganisms.
    Javed MR; Sadaf M; Ahmed T; Jamil A; Nawaz M; Abbas H; Ijaz A
    Curr Microbiol; 2018 Dec; 75(12):1675-1683. PubMed ID: 30078067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-dependent DNA endonuclease Cas9 of the CRISPR system: Holy Grail of genome editing?
    Gasiunas G; Siksnys V
    Trends Microbiol; 2013 Nov; 21(11):562-7. PubMed ID: 24095303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of CRISPR/Cas9 mediated genome editing in farm animals].
    Xing YY; Yang Q; Ren J
    Yi Chuan; 2016 Mar; 38(3):217-26. PubMed ID: 27001476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
    Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
    Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology.
    Ishino Y; Krupovic M; Forterre P
    J Bacteriol; 2018 Apr; 200(7):. PubMed ID: 29358495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems.
    Liu KI; Ramli MNB; Sutrisnoh NB; Tan MH
    Methods Mol Biol; 2018; 1772():267-288. PubMed ID: 29754234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CRISPR-Cas Mechanism for Adaptive Immunity and Alternate Bacterial Functions Fuels Diverse Biotechnologies.
    Newsom S; Parameshwaran HP; Martin L; Rajan R
    Front Cell Infect Microbiol; 2020; 10():619763. PubMed ID: 33585286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
    Grenier F; Lucier JF; Rodrigue S
    Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
    Mashimo T
    Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CRISPR/Cas9 system for plant genome editing and beyond.
    Bortesi L; Fischer R
    Biotechnol Adv; 2015; 33(1):41-52. PubMed ID: 25536441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering.
    Liu Q; Zhang H; Huang X
    FEBS J; 2020 Feb; 287(4):626-644. PubMed ID: 31730297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
    Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
    BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA-guided CRISPR-Cas technologies for genome-scale investigation of disease processes.
    Humphrey SE; Kasinski AL
    J Hematol Oncol; 2015 Apr; 8():31. PubMed ID: 25888285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas9: A revolution in genome editing in rheumatic diseases.
    Duroux-Richard I; Giovannangeli C; Apparailly F
    Joint Bone Spine; 2017 Jan; 84(1):1-4. PubMed ID: 27825565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 34.